CORT Mar 2025 50.000 call
| Previous close | 1.7000 |
| Open | 1.7000 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 50.00 |
| Expiry date | 2025-03-21 |
| Day's range | 1.7000 - 1.7000 |
| Contract range | N/A |
| Volume | |
| Open interest | 3 |
ZacksWall Street Analysts Think Corcept (CORT) Could Surge 41.31%: Read This Before Placing a Bet
The average of price targets set by Wall Street analysts indicates a potential upside of 41.3% in Corcept (CORT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
ZacksIs Alnylam Pharmaceuticals (ALNY) Stock Outpacing Its Medical Peers This Year?
Here is how Alnylam Pharmaceuticals (ALNY) and Corcept Therapeutics (CORT) have performed compared to their sector so far this year.
Insider MonkeyDoes Corcept Therapeutics (CORT) Have a Long Runway for Growth?
ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Value Strategy” second quarter 2024 investor letter. A copy of the letter can be downloaded here. Despite strong performance from healthcare holdings, the Strategy lagged its benchmark, the Russell 2000 Value Index, due to headwinds in the materials and industrial sectors. While investors continued […]
